0001235802-19-000063.txt : 20190626 0001235802-19-000063.hdr.sgml : 20190626 20190626163638 ACCESSION NUMBER: 0001235802-19-000063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190624 FILED AS OF DATE: 20190626 DATE AS OF CHANGE: 20190626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parsons James T. CENTRAL INDEX KEY: 0001759855 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36291 FILM NUMBER: 19922090 MAIL ADDRESS: STREET 1: 2 CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc. CENTRAL INDEX KEY: 0001401040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 BUSINESS PHONE: (763) 496-5454 MAIL ADDRESS: STREET 1: 2 CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 FORMER COMPANY: FORMER CONFORMED NAME: DiaMedica Inc. DATE OF NAME CHANGE: 20070525 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-06-24 0 0001401040 DiaMedica Therapeutics Inc. DMAC 0001759855 Parsons James T. 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 1 0 0 0 Voting Common Shares, no par value per share 6100 D Stock Option (right to buy) 4.6 2019-06-24 4 A 0 12950 0 A 2029-06-23 Common Shares 12950 12950 D Includes 3,850 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan. Vests in four nearly equal quarterly installments over one year. /s/ Amy Culbert, attorney-in-fact 2019-06-26